Opinion on Other

Published within

« | 1 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Eli Lilly: offsetting generic erosion through Janssen's animal health business

Over the coming years, Eli Lilly faces declining sales stemming from the patent expiries of two key products. Driven by this, Elanco, a division of Eli Lilly, has made an irrevocable offer to acquire Janssen's animal health business. Completion of this deal would allow Lilly to expand its geographic presence and increase its animal health business portfolio, offsetting potential losses.

Published By Datamonitor
17 Mar 2011

« | 1 | » »|

No help is available.